The role of the pharmacist in supporting multi-disciplinary education

Comment: Immunogenicity of biosimilars

Comment: Critical quality attributes of biosimilars

Comment: Use of biosimilar monoclonal antibodies in the clinic

Comment: Supporting a sustainable biosimilar solution

Highlights from ESMO 2019

Holistic management of patients with ALK-positive NSCLC

Role of molecular diagnostics in prostate cancer

Real-world use of carfilzomib in relapsed multiple myeloma patients with pre-existing cardiovascular comorbidities

Practical considerations for introducing biosimilars

Successful implementation of biosimilars through effective communication

How real-world data generation can assist biosimilar implementation